Development of Triple-negative breast cancer (TNBC) syngeneic models and TROP2-directed antibody-drug conjugate (ADC) surrogate to model therapeutic combinations

被引：0
|
作者：
Chou, Chih-Chien
Kardos, Jordan
Yang, Becky
Orf, Jessica
Dave, Rutwij
Lai, Yurong
Lee, Chingwei V.
Papalia, Giuseppe A.
Boyd, Kelli
Diehl, Lauri
Scholler, Nathalie
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-07-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-07-12
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Current state of clinical development of TROP2-directed antibody-drug conjugates for triple-negative breast cancer
    Marhold, Maximilian
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (02) : 129 - 132
  • [2] Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial
    Bardia, A.
    Juric, D.
    Shimizu, T.
    Tolcher, A.
    Karim, R.
    Spira, A.
    Mukohara, T.
    Lisberg, A. E.
    Kogawa, T.
    Krop, I.
    Papadopoulos, K. P.
    Hamilton, E.
    Damodaran, S.
    Greenberg, J.
    Gu, W.
    Kobayashi, F.
    Guevara, F.
    Jikoh, T.
    Kawasaki, Y.
    Meric-Bernstam, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S60 - S60
  • [3] Current state of clinical development of TROP2-directed antibody–drug conjugates for triple-negative breast cancer
    Maximilian Marhold
    memo - Magazine of European Medical Oncology, 2022, 15 : 129 - 132
  • [4] Antibody-Drug Conjugates (ADCs): A Novel Therapy for Triple-Negative Breast Cancer (TNBC)
    Gupta, Gaurav
    Hussain, Md Sadique
    Pant, Kumud
    Ali, Haider
    Thapa, Riya
    Bhat, Asif Ahmad
    CURRENT CANCER DRUG TARGETS, 2025, 25 (02) : 108 - 112
  • [5] New Biomarkers in a Novel Antibody-Drug Conjugate for Triple-Negative Breast Cancer
    Nagayama, Aiko
    ONCOLOGIST, 2018, 23 : S5 - S5
  • [6] Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates
    Kaboli, Parham Jabbarzadeh
    Shabani, Shima
    Sharma, Sagar
    Nasr, Minoo Partovi
    Yamaguchi, Hirohito
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (04): : 1671 - 1685
  • [7] IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results
    Goldenberg, David M.
    Vahdat, Linda T.
    Starodub, Alexander N.
    Bardia, Aditya
    Chuang, Ellen
    Moroose, Rebecca L.
    Diamond, Jennifer R.
    Sharkey, Robert M.
    Maliakal, Pius P.
    Hamburger, Steven A.
    Ocean, Allyson J.
    CANCER RESEARCH, 2015, 75
  • [8] Sacituzumab govitecan: a new antibody-drug conjugate for metastatic triple-negative breast cancer
    Banys-Paluchowski, M.
    Krawczyk, Natalia
    ONKOLOGE, 2021, 27 (03): : 287 - 290
  • [9] Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy
    Si, Yingnan
    Xu, Yuanxin
    Guan, JiaShiung
    Chen, Kai
    Kim, Seulhee
    Yang, Eddy S.
    Zhou, Lufang
    Liu, Xiaoguang Margaret
    ENGINEERING IN LIFE SCIENCES, 2021, 21 (1-2): : 37 - 44
  • [10] Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs
    Tang, Qi
    Li, Hui
    Zhao, Xin Tong
    Li, Ze Ying
    Ma, Chun Xiao
    Zhou, Shao Qiang
    Chen, De Dian
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (04) : 527 - 542
12345